Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli D Ehrenpreis

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Disease-A-Month : DM|September 28, 2011
ConstipationParakkal Deepak, Eli D Ehrenpreis
Disease-A-Month : DM|September 28, 2011
DiarrheaParakkal Deepak, Eli D Ehrenpreis
Disease-A-Month : DM|September 28, 2011
Other effects on the colonParakkal Deepak, Eli D Ehrenpreis
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates|January 31, 2016
Attitudes and Usage of the Food and Drug Administration Adverse Event Reporting System Among Gastroenterology Nurse Practitioners and Physician AssistantsAllison Salk, Eli D Ehrenpreis
The American Journal of the Medical Sciences|January 27, 2022
A Historical Perspective of Healthcare Disparity and Infectious Disease in the Native American PopulationJamie E Ehrenpreis, Eli D Ehrenpreis
Alimentary Pharmacology & Therapeutics|July 8, 2022
Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function aloneEli D Ehrenpreis, David H Kruchko
Papillomavirus Research (Amsterdam, Netherlands)|December 23, 2017
Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic modelEli D Ehrenpreis, Dylan G Smith
Journal of Clinical Gastroenterology|June 13, 2020
Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 InfectionsEli D Ehrenpreis, David H Kruchko
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
Alvimopan (Adolor/GlaxoSmithKline)Ijeoma A Azodo, Eli D Ehrenpreis
Journal of Clinical Gastroenterology|August 18, 2015
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric PanniculitisGrigory Roginsky, Aimee Alexoff, Eli D Ehrenpreis
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Disease-A-Month : DM|September 28, 2011
ConstipationParakkal Deepak, Eli D Ehrenpreis
Disease-A-Month : DM|September 28, 2011
DiarrheaParakkal Deepak, Eli D Ehrenpreis
Disease-A-Month : DM|September 28, 2011
Other effects on the colonParakkal Deepak, Eli D Ehrenpreis
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates|January 31, 2016
Attitudes and Usage of the Food and Drug Administration Adverse Event Reporting System Among Gastroenterology Nurse Practitioners and Physician AssistantsAllison Salk, Eli D Ehrenpreis
The American Journal of the Medical Sciences|January 27, 2022
A Historical Perspective of Healthcare Disparity and Infectious Disease in the Native American PopulationJamie E Ehrenpreis, Eli D Ehrenpreis
Alimentary Pharmacology & Therapeutics|July 8, 2022
Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function aloneEli D Ehrenpreis, David H Kruchko
Papillomavirus Research (Amsterdam, Netherlands)|December 23, 2017
Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic modelEli D Ehrenpreis, Dylan G Smith
Journal of Clinical Gastroenterology|June 13, 2020
Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 InfectionsEli D Ehrenpreis, David H Kruchko
Current Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
Alvimopan (Adolor/GlaxoSmithKline)Ijeoma A Azodo, Eli D Ehrenpreis
Journal of Clinical Gastroenterology|August 18, 2015
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric PanniculitisGrigory Roginsky, Aimee Alexoff, Eli D Ehrenpreis
Pageof 8